MeSH term
Frequency | Condition_Probility | Adult | 11 | 0.0 |
Aged | 10 | 0.0 |
Chromosomes, Human, Pair 16/*genetics | 6 | 6.0 |
Female | 13 | 0.0 |
Humans | 26 | 0.0 |
In Situ Hybridization, Fluorescence | 9 | 0.0 |
*Inversion, Chromosome | 13 | 17.0 |
Male | 12 | 0.0 |
Middle Aged | 8 | 0.0 |
Alleles | 2 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Myosin Heavy Chains/*genetics | 3 | 7.0 |
Research Support, Non-U.S. Gov't | 21 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
*Translocation, Genetic | 3 | 0.0 |
Adolescent | 6 | 0.0 |
Chromosomes, Human, Pair 22/genetics | 2 | 2.0 |
Inversion, Chromosome | 5 | 7.0 |
Oncogene Proteins, Fusion/genetics | 2 | 2.0 |
Karyotyping | 5 | 0.0 |
Leukemia, Myelomonocytic, Acute/*genetics | 4 | 16.0 |
Oncogene Proteins, Fusion/*genetics | 7 | 3.0 |
Acute Disease | 4 | 0.0 |
Chromosomes, Human, Pair 16/genetics | 2 | 2.0 |
DNA Primers/chemistry | 2 | 0.0 |
Leukemia, Myeloid/*genetics | 2 | 1.0 |
*Chromosomes, Human, Pair 16 | 9 | 3.0 |
Eosinophils/pathology | 2 | 5.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Base Sequence | 11 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Multidrug Resistance-Associated Proteins | 2 | 2.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Leukemia, Myelocytic, Acute/*genetics | 4 | 3.0 |
Translocation, Genetic | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Polymerase Chain Reaction | 8 | 0.0 |
DNA Primers | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Infant | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Child | 3 | 0.0 |
Chromosomes, Human, Pair 16/*ultrastructure | 2 | 40.0 |
*Neoplasm Proteins | 4 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Child, Preschool | 2 | 0.0 |
Chimeric Proteins/genetics | 2 | 3.0 |
DNA-Binding Proteins/*genetics | 5 | 0.0 |
Myosins/*genetics | 6 | 11.0 |
Transcription Factors/*genetics | 6 | 0.0 |
Chromosomes, Human, Pair 16 | 2 | 1.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Animals | 3 | 0.0 |
Mice | 2 | 0.0 |
Muscle, Smooth/*metabolism | 2 | 8.0 |
Restriction Mapping | 2 | 0.0 |
